OneVentures
Team Portfolio Funds Entrepreneurs Blog News Investors
TeamPortfolioFundsEntrepreneursBlogNewsInvestors
OneVentures

Hatchtech gets lice treatment nod from FDA

 

Read more from the Australian Financial Review below.

Learn more
 
AFRCarolyn MillerAugust 3, 2020Hatchtech, Paul Kelly
Twitter LinkedIn0 0 Likes
Previous

KiRA Biotech appoints Global Pharma Business Leader as Independent Board Chair

Media ReleaseCarolyn MillerAugust 3, 2020Kira Biotech, Paul Kelly
Next

FDA Approves Xeglyze™ for the topical treatment of head lice infestation

Media ReleaseCarolyn MillerAugust 3, 2020Hatchtech, Paul Kelly

Suite 13.02, 179 Elizabeth Street, Sydney NSW 2000

enquiries@one-ventures.com

+61 2 8205 7379


Disclaimer

Responsible Investment Policy

Privacy Policy

 
 
OneVentures Pty Ltd
179 Elizabeth Street (Suite 13.02),
Sydney, NSW, 2000,
Australia
+61 2 8205 7379 enquiries@one-ventures.com
Hours

Copyright © 2017 OneVentures Pty Ltd